These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 7849582)
1. The three-dimensional structures of mutants of porphobilinogen deaminase: toward an understanding of the structural basis of acute intermittent porphyria. Brownlie PD; Lambert R; Louie GV; Jordan PM; Blundell TL; Warren MJ; Cooper JB; Wood SP Protein Sci; 1994 Oct; 3(10):1644-50. PubMed ID: 7849582 [TBL] [Abstract][Full Text] [Related]
2. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties. Ulbrichova D; Hrdinka M; Saudek V; Martasek P FEBS J; 2009 Apr; 276(7):2106-15. PubMed ID: 19292878 [TBL] [Abstract][Full Text] [Related]
3. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria. Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865 [TBL] [Abstract][Full Text] [Related]
4. Molecular basis of acute intermittent porphyria. Wood S; Lambert R; Jordan PM Mol Med Today; 1995 Aug; 1(5):232-9. PubMed ID: 17607885 [TBL] [Abstract][Full Text] [Related]
5. A new mutation within the porphobilinogen deaminase gene leading to a truncated protein as a cause of acute intermittent porphyria in an extended Indian family. Flachsová E; Verma IC; Ulbrichová D; Saxena R; Zeman J; Saudek V; Raman CS; Martásek P Folia Biol (Praha); 2007; 53(6):194-201. PubMed ID: 18070416 [TBL] [Abstract][Full Text] [Related]
6. CRIM-positive mutations of acute intermittent porphyria in Finland. Kauppinen R; Peltonen L; Pihlaja H; Mustajoki P Hum Mutat; 1992; 1(5):392-6. PubMed ID: 1301948 [TBL] [Abstract][Full Text] [Related]
7. [The initial results of detecting mutations in the gene of the porphobilinogen deaminase enzyme in patients with acute intermittent porphyria in Russia]. Pivnik AV; Pustovoĭt IaS; Karpova IV; Surin VL; Luk'ianenko AV Ter Arkh; 2000; 72(7):5-8. PubMed ID: 10983313 [No Abstract] [Full Text] [Related]
8. Acute intermittent porphyria: a single-base deletion and a nonsense mutation in the human hydroxymethylbilane synthase gene, predicting truncations of the enzyme polypeptide. Lee GY; Astrin KH; Desnick RJ Am J Med Genet; 1995 Aug; 58(2):155-8. PubMed ID: 8533808 [TBL] [Abstract][Full Text] [Related]
9. A point mutation, C to T, in exon 8 of the porphobilinogen deaminase gene in a Japanese family with acute intermittent porphyria. Morita Y; Daimon M; Kashiwaba M; Yamatani K; Igarashi M; Fukase N; Ohnuma H; Ikezawa Y; Sugiyama K; Manaka H Jpn J Hum Genet; 1995 Jun; 40(2):207-13. PubMed ID: 7663002 [TBL] [Abstract][Full Text] [Related]
10. A novel 12-base pair deletion mutation in exon 15 of the porphobilinogen deaminase gene in a Taiwanese patient with acute intermittent porphyria. Sakabe J; Susa S; Daimon M; Lan MY; Kato T Blood Cells Mol Dis; 2008; 41(2):202. PubMed ID: 18554962 [No Abstract] [Full Text] [Related]
11. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria. Gregor A; Schneider-Yin X; Szlendak U; Wettstein A; Lipniacka A; Rüfenacht UB; Minder EI Hum Mutat; 2002 Mar; 19(3):310. PubMed ID: 11857754 [TBL] [Abstract][Full Text] [Related]
12. Residual activity of human porphobilinogen deaminase with R167Q or R167W mutations: an explanation for survival of homozygous and compound heterozygous acute intermittent porphyrics. Edixhoven-Bosdijk A; de Rooij FW; de Baar-Heesakkers E; Wilson JH Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):861-6. PubMed ID: 12699244 [TBL] [Abstract][Full Text] [Related]
13. [Three new mutations in the porphobilinogen deaminase gene, detected in acute intermittent porphyria patients from Russia]. Surin VL; Luk'ianenko AV; Karpova IV; Misiurin AV; Pustovot IaS; Pivnik AV Genetika; 2001 May; 37(5):690-7. PubMed ID: 11436563 [TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations. von Brasch L; Zang C; Haverkamp T; Schlechte H; Heckers H; Petrides PE Blood Cells Mol Dis; 2004; 32(2):309-14. PubMed ID: 15003823 [TBL] [Abstract][Full Text] [Related]
16. Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria. Delfau MH; Picat C; de Rooij FW; Hamer K; Bogard M; Wilson JH; Deybach JC; Nordmann Y; Grandchamp B J Clin Invest; 1990 Nov; 86(5):1511-6. PubMed ID: 2243128 [TBL] [Abstract][Full Text] [Related]
17. Molecular forms of porphobilinogen deaminase in acute intermittent porphyria. A study by Western immunoblotting. Nunn AV; Gardner LC; Cox TM Q J Med; 1987 Jul; 64(243):589-99. PubMed ID: 3671663 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis of acute intermittent porphyria: mutations and polymorphisms in the human hydroxymethylbilane synthase gene. Astrin KH; Desnick RJ Hum Mutat; 1994; 4(4):243-52. PubMed ID: 7866402 [TBL] [Abstract][Full Text] [Related]